News Overview

Moving annual turnover (MAT) from April 2023 to March 2024 increased by 6.5%, totaling Rs 1.98 trillion, while domestic market volumes dipped by 1%.

Collaborating closely with Orbicular Pharmaceutical Technologies Private Limited, Gland Pharma is actively engaged in the co-development of several complex injectables, including Eribulin Mesylate Injection.

The NFO is available for subscription from April 08 to April 22. The schemes will reopen for continuous sale and repurchase within five Business Days from the date of allotment.

Full-year sales witnessed a 20% YoY increase, with wholesale volumes reaching 401,303 units (up 25%) and retail sales totaling 431,733 units (up 22%).

The company is raising ₹100 Crore from the issue at a price of ₹1000 each. Investors need to apply for a minimum of 10 NCDs in a lot.

Sula Vineyards was up 2.6% at ₹570 as of 10:41 a.m. The company's shares have increased by 60% in the last year.

SA20 and ILT20 are franchise-based twenty20 competitions modelled after the IPL, founded by the South African and United Arab Emirates cricket boards, respectively.

Moneycontrol reported on April 8 that Bain Capital intended to leave the private sector lender, despite the fact that the identities of the persons directly involved in the transaction could not be immediately determined.

Gland Pharma is promoted by Fosun Pharma, a Chinese company that owns 57.86% of the company.

Since starting on the new post in February, Tahilyani has been carefully steered by Chandrasekaran, who wants to see the consumer app develop traction before pursuing external investor interest.